The Venture Codex Logo

The Venture Codex

BioVentures Investors

16 Laurel Street Suite 150, Wellesley, MA, 02481, United States

Overview

Private equity firm investing in life sciences and healthcare.

Founded

1998

Deals ยท 12mo

0

Links

WebsiteLinkedIn

Stage focus

Series A
Series D

Geographic focus

China
France
United States

Sector focus

Health Care
Life Science
Venture Capital

Investment portfolio

10rounds
NAMEDATESIZE
AbolerIS Pharma
Sep 2023Participated
$29 MSeries A
Pathology Watch
Dec 2020Participated
$2 MSeries A
BRAINBox Solutions
Dec 2020Led
$23 MSeries A
Sonomotion
Nov 2019Participated
$10 MSeries B
Endotronix
Oct 2019Participated
$70 MSeries D
RainSure Scientific
Sep 2019Led
$1 MSeries A
Endotronix
Sep 2018Participated
$45 MSeries D
Endotronix
Jul 2016Participated
$32 MSeries C
Ascentage Pharma
Aug 2015Participated
$16 MSeries A
Cylene Pharmaceuticals
Sep 2010Participated
$12 MOther Equity
AbolerIS Pharma
Sep 2023Participated
$29 MSeries A
Pathology Watch
Dec 2020Participated
$2 MSeries A
BRAINBox Solutions
Dec 2020Led
$23 MSeries A
Sonomotion
Nov 2019Participated
$10 MSeries B
Endotronix
Oct 2019Participated
$70 MSeries D
RainSure Scientific
Sep 2019Led
$1 MSeries A
Endotronix
Sep 2018Participated
$45 MSeries D
Endotronix
Jul 2016Participated
$32 MSeries C
Ascentage Pharma
Aug 2015Participated
$16 MSeries A
Cylene Pharmaceuticals
Sep 2010Participated
$12 MOther Equity
10
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

BioVentures Investors: 10 funding rounds are recorded in the selected participation categories.All available history.
BioVentures Investors: 10 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A23
Series B01
Series C+03
Other Equity01

Monthly Deal Activity

BioVentures Investors: 10 deals are recorded across 194 months.All available history.
BioVentures Investors: 10 deals are recorded across 194 months. All available history
MonthDeals
Sep '101
Oct '100
Nov '100
Dec '100
Jan '110
Feb '110
Mar '110
Apr '110
May '110
Jun '110
Jul '110
Aug '110
Sep '110
Oct '110
Nov '110
Dec '110
Jan '120
Feb '120
Mar '120
Apr '120
May '120
Jun '120
Jul '120
Aug '120
Sep '120
Oct '120
Nov '120
Dec '120
Jan '130
Feb '130
Mar '130
Apr '130
May '130
Jun '130
Jul '130
Aug '130
Sep '130
Oct '130
Nov '130
Dec '130
Jan '140
Feb '140
Mar '140
Apr '140
May '140
Jun '140
Jul '140
Aug '140
Sep '140
Oct '140
Nov '140
Dec '140
Jan '150
Feb '150
Mar '150
Apr '150
May '150
Jun '150
Jul '150
Aug '151
Sep '150
Oct '150
Nov '150
Dec '150
Jan '160
Feb '160
Mar '160
Apr '160
May '160
Jun '160
Jul '161
Aug '160
Sep '160
Oct '160
Nov '160
Dec '160
Jan '170
Feb '170
Mar '170
Apr '170
May '170
Jun '170
Jul '170
Aug '170
Sep '170
Oct '170
Nov '170
Dec '170
Jan '180
Feb '180
Mar '180
Apr '180
May '180
Jun '180
Jul '180
Aug '180
Sep '181
Oct '180
Nov '180
Dec '180
Jan '190
Feb '190
Mar '190
Apr '190
May '190
Jun '190
Jul '190
Aug '190
Sep '191
Oct '191
Nov '191
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '200
Aug '200
Sep '200
Oct '200
Nov '200
Dec '202
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '231
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

BioVentures Investors: Health & Life Sciences is the largest displayed sector by deal count (10 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

BioVentures Investors: Health & Life Sciences is the largest displayed sector by deal count (10 deals). All available history
SectorDeals
Health & Life Sciences10
Networks, Cloud & Communication3
Manufacturing2
Professional Services1

Deal Size Distribution

BioVentures Investors: 10 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

BioVentures Investors: 10 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M2
$5M-$10M0
$10M-$25M4
$25M-$50M3
$50M-$100M1
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

BioVentures Investors: United States has the largest recorded deal count among the displayed regions (7 deals).All available history.

Top 3 of 3 regions; European countries are grouped as Europe.

BioVentures Investors: United States has the largest recorded deal count among the displayed regions (7 deals). All available history
RegionDeals
United States7
China2
Europe1
BioVentures Investors: 20 co-investors are shown, with Aperture Venture Partners sharing 3 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

BioVentures Investors: 20 co-investors are shown, with Aperture Venture Partners sharing 3 recorded deals. All available history
Co-investorShared deals
Aperture Venture Partners3
Lumira Ventures3
OSF Ventures3
SV Health Investors3
Seroba Life Sciences2
Wanxiang Healthcare Investments2
500 Global1
Advanced MedTech1
Astia Angels1
Beni VC1
Caixa Capital Risc1
Efung Capital1
EQT Life Sciences (LSP)1
Future Capital1
Genoa Ventures1
Grains Valley Venture Capital1
HBM Healthcare Investments1
Lateral Capital1
Lilly Ventures1
MedVenture Partners1

Investment Strategy

BioVentures Investors: Led accounts for 20% and participating for 80% of round participation.All available history.
BioVentures Investors: Led accounts for 20% and participating for 80% of round participation. All available history
CategoryDeals (count)Share (%)
Led220%
Participating880%
BioVentures Investors: Single-lead accounts for 100% and co-led for 0% of lead dynamics.All available history.
BioVentures Investors: Single-lead accounts for 100% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead2100%
Co-led00%

Team

Jeffrey Barnes

General Partner

Jonathan Gertler

Managing Director

Marc Goldberg

Co-Founder & Managing Partner

Peter Feinstein

Venture Partner

Walter Gilbert

General Partner